VACCINATION COVERAGE AGAINST INFLUENZA AND PNEUMOCOCCAL INFECTIONS IN ADULTS WITH RESPIRATORY DISORDERS – NEED FOR COMPREHENSIVE INTERVENTION
AbstractAdults with chronic respiratory conditions are at heightened risk for preventable lung infections, yet vaccine uptake against influenza and pneumococcal diseases remains suboptimal. This hospital-based cross-sectional study aimed to assess factors influencing vaccination coverage and identify individuals who may benefit from targeted interventions. A total of 118 adult patients attending an outpatient respiratory diseases clinic were surveyed using a self-developed questionnaire evaluating knowledge, attitudes, and practices related to vaccination. More than half of the participants recognised influenza as a risk factor for pneumonia and were aware of the corresponding vaccines. Interestingly, COVID-19 vaccination appeared to positively influence vaccine-related knowledge. Despite generally favourable attitudes, actual immunisation rates were low, revealing a gap between intention and practice. A key finding was the lack of proactive guidance from healthcare providers, which emerged as a significant barrier. Other obstacles included limited awareness and persistent safety misconceptions. While cost was not broadly perceived as a barrier, 44% expressed willingness to vaccinate only if it were offered free of charge. No significant correlation was observed between age and vaccination attitudes or practices, likely due to the limited sample size. The study underscores the urgent need for sustained educational efforts and stronger healthcare provider engagement to improve immunisation uptake among high-risk adults.
Article Information
33
351-357
569 KB
11
English
IJPSR
Ajas Asharaf, Diya Elizabeth Manoj, Muhammed Shahzin, Nasreen Nassar, K. Ebenz Chalson, Nimshitha Abdul Muneer, Sona Sagi and Binai K. Sankar *
Department of Pharmacy Practice, Al Shifa College of Pharmacy, Perinthalmanna, Kerala, India.
Binai@alshifacollegeofpharmacy.ac.in
28 June 2025
15 July 2025
21 July 2025
10.13040/IJPSR.0975-8232.17(1).351-57
01 January 2026





